Clinical Roundup New approach to managing post-surgery pain reduces opioid-based medication use by 50% December 02, 2022Vol.48 No.43
Clinical Roundup Estrogen-blocking drugs could offer mortality benefit for women with elevated breast cancer risk December 02, 2022Vol.48 No.43
Clinical Roundup Johns Hopkins researchers generate lab-grown human tissue model for gastroesophageal junction cancer December 02, 2022Vol.48 No.43
Clinical Roundup AI-enabled study shows mechanics of aging and disease progression December 02, 2022Vol.48 No.43
Clinical Roundup Multicenter study reveals worse outcomes in understudied breast cancer December 02, 2022Vol.48 No.43
Drugs & Targets FDA approves Rezlidhia for R/R AML with a susceptible IDH1 mutation December 02, 2022Vol.48 No.43
Drugs & Targets Genentech voluntarily withdraws U.S. indication of Tecentriq for types of bladder cancer December 02, 2022Vol.48 No.43
Drugs & Targets AstraZeneca to acquire Neogene Therapeutics for $320M to develop T cell receptor therapies December 02, 2022Vol.48 No.43
